Six novel minimally invasive therapies for benign prostatic hyperplasia / 浙江大学学报·医学版
Journal of Zhejiang University. Medical sciences
; (6): 162-168, 2023.
Article
в En
| WPRIM
| ID: wpr-982031
Ответственная библиотека:
WPRO
ABSTRACT
Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in men. When drug treatment is ineffective or conventional surgery is not suitable, novel minimally invasive therapies can be considered. These include prostatic urethral lift, prostatic artery embolisation, water vapor thermal therapy, Aquablation-image guided robotic waterjet ablation, temporary implantable nitinol device and prostatic stents. These novel therapies can be performed in outpatient setting under local anesthesia, with shorter operative and recovery times, and better protection of ejaculatory function and erectile function. General conditions of the patient and advantages and disadvantages of the each of these therapies should be fully considered to make individualized plans.
Key words
Полный текст:
1
База данных:
WPRIM
Основная тема:
Prostatic Hyperplasia
/
Stents
/
Treatment Outcome
/
Minimally Invasive Surgical Procedures
/
Embolization, Therapeutic
/
Lower Urinary Tract Symptoms
Пределы темы:
Humans
/
Male
Язык:
En
Журнал:
Journal of Zhejiang University. Medical sciences
Год:
2023
Тип:
Article